Antifibrinolytic Agents

Displaying 1 - 5 of 5CSV
Osawa, I., Goto, T., & Roberts, I. (2025). Tranexamic acid for trauma: optimal timing of administration based on the CRASH-2 and CRASH-3 trials. British Journal of Surgery, 112(4). https://doi.org/10.1093/bjs/znaf079
Publication Date
Mullin, J. P., Soliman, M. A. R., Smith, J. S., Kelly, M. P., Buell, T. J., Diebo, B., Scheer, J. K., Line, B., Lafage, V., Lafage, R., Klineberg, E., Kim, H. J., Passias, P. G., Gum, J. L., Kebaish, K., Eastlack, R. K., Daniels, A. H., Soroceanu, A., Mundis, G., … Burton, D. (2024). Analysis of tranexamic acid usage in adult spinal deformity patients with relative contraindications: does it increase the risk of complications? Journal of Neurosurgery: Spine, 1–8. https://doi.org/10.3171/2024.1.spine231098
Publication Date
Selden, C. R., Schilling, K., Godfrey, L., & Yee, N. (2024). Metal-binding amino acid ligands commonly found in metalloproteins differentially fractionate copper isotopes. Scientific Reports, 14(1). https://doi.org/10.1038/s41598-024-52091-7
Publication Date
Clohisy, J. C. F., Lenke, L. G., Dafrawy, M. H. E., Wolfe, R. C., Frazier, E., & Kelly, M. P. (2022). Randomized, controlled trial of two tranexamic acid dosing protocols in adult spinal deformity surgery. Spine Deformity, 10(6), 1399–1406. https://doi.org/10.1007/s43390-022-00539-z
Publication Date